Published in Ann Allergy Asthma Immunol on March 01, 2003
Aspirin-exacerbated respiratory disease: evaluation and management. Allergy Asthma Immunol Res (2010) 1.19
Prostaglandin E2 deficiency uncovers a dominant role for thromboxane A2 in house dust mite-induced allergic pulmonary inflammation. Proc Natl Acad Sci U S A (2012) 1.04
Rhinosinusitis and aspirin-exacerbated respiratory disease. J Allergy (Cairo) (2012) 0.80
Aspirin sensitivity and chronic rhinosinusitis with polyps: a fatal combination. J Allergy (Cairo) (2012) 0.79
Sinonasal outcome under aspirin desensitization following functional endoscopic sinus surgery in patients with aspirin triad. Eur Arch Otorhinolaryngol (2012) 0.78
A retrospective study of the clinical benefit from acetylsalicylic acid desensitization in patients with nasal polyposis and asthma. Allergy Asthma Clin Immunol (2014) 0.78
Update on the Management of Aspirin-Exacerbated Respiratory Disease. Allergy Asthma Immunol Res (2016) 0.75
Contemporary management of chronic rhinosinusitis with nasal polyposis in aspirin-exacerbated respiratory disease: an evidence-based review with recommendations. Int Forum Allergy Rhinol (2016) 0.75
Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol (2010) 5.55
Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report. J Allergy Clin Immunol (2010) 2.98
Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol (2003) 2.26
Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial. Am J Respir Crit Care Med (2002) 1.90
Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper. Ann Allergy Asthma Immunol (2007) 1.77
The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol (2005) 1.69
Food allergy: a practice parameter update-2014. J Allergy Clin Immunol (2014) 1.60
Excess dampness and mold growth in homes: an evidence-based review of the aeroirritant effect and its potential causes. Allergy Asthma Proc (2007) 1.51
Aspirin-exacerbated respiratory disease: evaluation and management. Allergy Asthma Immunol Res (2010) 1.19
The natural history and clinical characteristics of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol (2002) 1.14
Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-sponsored expert panel report. Nutr Res (2011) 1.14
Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol (2003) 1.12
The safety of celecoxib in patients with aspirin-sensitive asthma. Arthritis Rheum (2002) 1.09
Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol (2006) 1.00
The united allergic airway: connections between allergic rhinitis, asthma, and chronic sinusitis. Am J Rhinol Allergy (2012) 0.98
Aspirin sensitivity: implications for patients with coronary artery disease. JAMA (2004) 0.97
Effect of leukotriene modifier drugs on the safety of oral aspirin challenges. Ann Allergy Asthma Immunol (2006) 0.96
Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps, and chronic sinusitis. Ann Allergy Asthma Immunol (2008) 0.95
Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-Sponsored Expert Panel Report. Nutrition (2011) 0.92
Selection of patients for aspirin desensitization treatment. J Allergy Clin Immunol (2006) 0.90
Sensitivity to nonsteroidal anti-inflammatory drugs. Ann Allergy Asthma Immunol (2002) 0.86
Use of intranasal ketorolac and modified oral aspirin challenge for desensitization of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol (2010) 0.86
Aspirin-exacerbated respiratory disease: burden of disease. Allergy Asthma Proc (2012) 0.85
Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-Sponsored Expert Panel report. J Am Acad Dermatol (2011) 0.85
Rational approach to aspirin dosing during oral challenges and desensitization of patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol (2008) 0.85
The relationship between historical aspirin-induced asthma and severity of asthma induced during oral aspirin challenges. J Allergy Clin Immunol (2007) 0.83
Clopidogrel desensitization after drug-eluting stent placement. J Am Coll Cardiol (2007) 0.83
An epidemic of over diagnosing drug allergies. Allergy Asthma Proc (2014) 0.83
The clinical dilemma of "silent desensitization" in aspirin-exacerbated respiratory disease. Allergy Asthma Proc (2013) 0.82
Aspirin-exacerbated respiratory disease: update on pathogenesis and desensitization. Semin Respir Crit Care Med (2012) 0.81
Failure to maintain an aspirin-desensitized state in a patient with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol (2006) 0.79
Does it make sense to "desens"? Aspirin desensitization in the treatment of chronic rhinosinusitis. Curr Allergy Asthma Rep (2006) 0.78
Safety of high-dose rofecoxib in patients with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol (2004) 0.78
Cardiovascular prophylaxis and aspirin "allergy". Immunol Allergy Clin North Am (2012) 0.78
Classification of reactions to nonsteroidal antiinflammatory drugs. Immunol Allergy Clin North Am (2012) 0.77
The Difficult-to-Control Asthmatic: A Systematic Approach. Allergy Asthma Clin Immunol (2006) 0.77
Aspirin desensitization in aspirin-exacerbated respiratory disease. Immunol Allergy Clin North Am (2012) 0.77
Supraesophageal reflux disease: a review of the literature. Allergy Asthma Proc (2014) 0.77
Does suppression of IL-4 synthesis by aspirin explain the therapeutic benefit of aspirin desensitization treatment? J Allergy Clin Immunol (2010) 0.77
Making the call: the diagnosis of acute community-acquired bacterial sinusitis. Am J Rhinol (2006) 0.77
Failure of tacrolimus to prevent aspirin-induced respiratory reactions in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol (2005) 0.76
Smoking, environmental tobacco smoke, and aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol (2011) 0.76
Aspirin as a cause of pancreatitis in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol (2012) 0.76
Evidence-based protocols for oral NSAID challenges. J Pediatr (2006) 0.75
Side effects from daily aspirin treatment in patients with AERD: Identification and management. Allergy Asthma Proc (2011) 0.75
Hydroxyurea in the treatment of Churg-Strauss syndrome. J Allergy Clin Immunol (2009) 0.75
Aspirin-exacerbated respiratory disease: is it in our DNA? Ann Allergy Asthma Immunol (2011) 0.75
Cross-reactivity of cyclooxygenase 2 inhibitors in patients with a history of cutaneous reactions to cyclooxygenase 1 inhibitors. Ann Allergy Asthma Immunol (2005) 0.75
Role of aspirin and other nonsteroidal anti-inflammatory drugs in aspirin-exacerbated respiratory disease. Expert Rev Clin Immunol (2006) 0.75
Nonsteroidal anti-inflammatory drug-induced reactions and desensitization. J Asthma (2004) 0.75
Macrolide antibiotics as anti-inflammatory agents. Curr Allergy Asthma Rep (2005) 0.75
Methicillin-resistant Staphylococcus aureus pelvic abscesses in a female after gynecologic pelvic surgery. Am J Obstet Gynecol (2011) 0.75
Assessment of sensitization risk of a laundry pre-spotter containing protease. Cutan Ocul Toxicol (2011) 0.75
Characterization of aspirin allergies in patients with coronary artery disease. Ann Allergy Asthma Immunol (2013) 0.75
Sinusitis and chronic progressive exercise-induced cough and dyspnea. Allergy Asthma Proc (2009) 0.75
Approach to patients with aspirin hypersensitivity and acute cardiovascular emergencies. Allergy Asthma Proc (2013) 0.75